Toll-like receptor 2 (TLR2), often designated as CD282 (cluster of differentiation 282) is a type I transmembrane protein belonging to the large homologous family of Toll like receptors.
Toll-like receptor 2 (TLR2),
often designated as CD282 (cluster of
differentiation 282) is a type I transmembrane protein belonging to the
large homologous family of Toll like receptors. TLR2 acts as functional
receptor for both Gram-positive and Gram-negative bacteria. Like all other
members of the TLR family, TLR2 is composed of an extracellular domain
containing multiple leucine-rich repeats (LRRs), a transmembrane
region, and a cytoplasmic tail containing the conserved TIR domain.
TLR2 maps to chromosome 4q31-32 and encodes a putative 784 amino acid protein
with 19 N-terminal LLRs and a calculated molecular weight of 84 kDa (1, 2, 3).
Comparison of the amino acid sequence reveals that TLR2, TLR1, and
TLR6 form a TLR subfamily, which presumably diverged from one common
ancestral gene. In humans, TLR10 is also a member of this TLR2
subfamily. Among all TLR, TLR1 and TLR6 have the highest identity of
overall amino acid sequence, which is 66%, and a similar genomic
structure and thus it is assumed that they are the evolutionary
products of gene duplication.
In vivo transcripts for TLR2 are
observed suggesting that the mRNA is alternatively spliced. TLR2 mRNA
expression is observed in brain, heart, lung, and spleen tissues and is highest
in PBLs, specifically those of myelomonocytic origin. In vitro
PMA-differentiated THP-1, TLR2 is most significantly upregulated by autocrine
IL-6 and TNF-α, IL-1β, and IL-10. Further, TLR2 mRNA expression is elevated
after exposure to both Gram-positive and Gram-negative bacteria. The increase
in TLR2 expression in monocytes and granulocytes on exposure to Gram-negative
bacteria is only very modest. Furthermore, TLR2 appears to be
up-regulated on mononuclear cells during disorders such as chronic
obstructive pulmonary disease, influenza virus infections, and
sepsis
TLR2 act as signal transducers
for various bacterial components which include lipoproteins derived from M.
tuberculosis, Borrelia burgdorfei, Treponema pallidium and Mycoplasma
fermentans. In
addition, TLR2 mediates cellular responses to a wide variety of infectious
pathogens and their products which include yeast cell walls, whole mycobacteria,
mycobacterial ara-lipoarabinomannan, whole Gram-positive bacteria,
peptidoglycan (PGN), Treponema glycolipid and Trypanosoma cruzi glycophosphatidylinositol
anchor. TLR2 forms heterodimers with TLR1, TLR6 and possibly TLR10, where each
complex is particularly sensitive to subsets of TLR2-associated pathogen-associated molecular patterns (PAMPs). It has been studied that TLR6 and TLR2
function together to detect Gram-positive bacteria, PGN and zymosan, whereas
TLR2 functions either alone or with TLRs other than TLR6 to detect bacterial
lipopeptides. More recent studies have suggested that, like TLR4, TLR2
complexes require CD14 and MD-2 for detection of PAMPs and signaling. (4,
5) Upon ligand recognition, TLR2 recruits both the TIR
domain-containing sorting adaptor TIRAP and the signaling adaptor MyD88, and
initiates the MyD88-dependent pathway. The MyD88-dependent pathway activates
nuclear factor (NF)-κB, activator protein-1 (AP-1) and interferon regulatory
factor 5 (IRF5), which induce inflammatory cytokine expression such as IL-6,
IL-12, and TNFα. (6)
Aside from detection of non-self patterns, TLR2 complexes
are also capable of detecting altered self patterns, such as those displayed by
necrotic cells. Further, recent evidence indicates that TLR2 is recruited to
phagosomes and may be directly involved in the internalization of microbial
products by cells.
Reference:
1. Rock, F.L. et
al. (1998) Proc. Natl. Acad. Sci. USA 95:588.
2. Chaudhary, P.M. et al. (1998) Blood 91:4020.
3. Dunne, A. & L.A.J. O'Neill (2003) Sci. STKE 2003:re3.
4. Modlin, R.L.
(2002) Ann. Allergy Asthma Immunol. 88:543.
5. J Endotoxin Res. 2000;6(5):401-5
6. Annual Review of Biochemistry Vol. 76: 447-480
(Publication date July 2007)
| Additional articles about Toll-like receptors |
|
|
| About the author |
IMGENEX India Pvt Ltd. the only biotech company in Orissa and one of its kinds in Eastern India. IMGENEX India started in Oct as an outsourcing branch of IMGENEX Corporation, San Diego, USA. Find out more information about Toll-like receptors .
|
| Please Rate This Article |
Number of ratings: 0
Rating: 0